New heart drug trial aims to ease strain for patients with thickened heart muscle
NCT ID NCT07367724
Summary
This study is testing whether a medication called ademetionine can help people with obstructive hypertrophic cardiomyopathy (oHCM), a condition where the heart muscle thickens and makes it harder to pump blood. About 44 participants will be randomly assigned to receive either the study drug or a placebo for 16 weeks. Researchers will check if the drug improves patients' ability to exercise, reduces heart failure symptoms, and is safe to use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (OHCM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fuwai Hospital
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Xinjiang Medical University
NOT_YET_RECRUITINGXinjiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Zhongshan Hospital, Shanghai Medical College of Fudan University
RECRUITINGShanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.